Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Oyagbemi, Ademola Adetokunbo
|
|
| dc.contributor.author | Omobowale, Temidayo Olutayo
|
|
| dc.contributor.author | Adejumobi, Olumuyiwa Abiola
|
|
| dc.contributor.author | Owolabi, Abiodun Mary
|
|
| dc.contributor.author | Ogunpolu, Blessing Seun
|
|
| dc.contributor.author | Falayi, Olufunke Olubunmi
|
|
| dc.contributor.author | Hassan, Fasilat Oluwakemi
|
|
| dc.contributor.author | Ogunmiluyi, Iyanuoluwa Omolola
|
|
| dc.contributor.author | Asenuga, Ebunoluwa Racheal
|
|
| dc.contributor.author | Ola-Davies, Olufunke Eunice
|
|
| dc.contributor.author | Soetan, Kehinde Olugboyega
|
|
| dc.contributor.author | Saba, Adebowale Benard
|
|
| dc.contributor.author | Adedapo, Adeolu Alex
|
|
| dc.contributor.author | Nkadimeng, Sanah Malomile
|
|
| dc.contributor.author | McGaw, Lyndy Joy
|
|
| dc.contributor.author | Oguntibeju, Oluwafemi Omoniyi
|
|
| dc.contributor.author | Yakubu, Momoh Audu
|
|
| dc.date.accessioned | 2023-10-31T08:49:22Z | |
| dc.date.available | 2023-10-31T08:49:22Z | |
| dc.date.issued | 2020-08 | |
| dc.description.abstract | Please read abstract in the article. | en_US |
| dc.description.department | Paraclinical Sciences | en_US |
| dc.description.librarian | hj2023 | en_US |
| dc.description.sponsorship | Cape Peninsula University of Technology and National Research Foundation (South Africa). | en_US |
| dc.description.uri | https://www.elsevier.com/locate/ejphar | en_US |
| dc.identifier.citation | Oyagbemi, A.A., Omobowale, T.O., Adejumobi, O.A. et al. 2020, 'Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway', European Journal of Pharmacology, vol. 880, art. 173142, pp. 1-13, doi : 10.1016/j.ejphar.2020.173142. | en_US |
| dc.identifier.issn | 0014-2999 (print) | |
| dc.identifier.issn | 1879-0712 (online) | |
| dc.identifier.other | 10.1016/j.ejphar.2020.173142 | |
| dc.identifier.uri | http://hdl.handle.net/2263/93122 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.rights | © 2020 Elsevier B.V. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in European Journal of Pharmacology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in European Journal of Pharmacology, vol. 880, art. 173142, pp. 1-13, doi : 10.1016/j.ejphar.2020.173142. | en_US |
| dc.subject | Hypertension (HTN) | en_US |
| dc.subject | Oxidative stress | en_US |
| dc.subject | Naringenin | en_US |
| dc.subject | Novel-antihypertensive agent | en_US |
| dc.subject | SDG-03: Good health and well-being | en_US |
| dc.subject | Antihypertensive power | en_US |
| dc.subject | Mineralocorticoid receptor (MCR) | en_US |
| dc.subject | Angiotensin converting enzyme (ACE) | en_US |
| dc.subject | Kidney injury molecule (Kim-1) | en_US |
| dc.title | Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway | en_US |
| dc.type | Postprint Article | en_US |
